219 related articles for article (PubMed ID: 33507976)
1. Pharmacological upregulation of GLT-1 alleviates the cognitive impairments in the animal model of temporal lobe epilepsy.
Ramandi D; Elahdadi Salmani M; Moghimi A; Lashkarbolouki T; Fereidoni M
PLoS One; 2021; 16(1):e0246068. PubMed ID: 33507976
[TBL] [Abstract][Full Text] [Related]
2. Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice.
Fan S; Xian X; Li L; Yao X; Hu Y; Zhang M; Li W
J Alzheimers Dis; 2018; 66(4):1731-1743. PubMed ID: 30452416
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury.
Verma R; Mishra V; Sasmal D; Raghubir R
Eur J Pharmacol; 2010 Jul; 638(1-3):65-71. PubMed ID: 20423712
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of GLT-1 by treatment with ceftriaxone alleviates radicular pain by reducing spinal astrocyte activation and neuronal hyperexcitability.
Nicholson KJ; Gilliland TM; Winkelstein BA
J Neurosci Res; 2014 Jan; 92(1):116-29. PubMed ID: 24123246
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone, a GLT-1 transporter activator, disrupts hippocampal learning in rats.
Matos-Ocasio F; Hernández-López A; Thompson KJ
Pharmacol Biochem Behav; 2014 Jul; 122():118-21. PubMed ID: 24650590
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Synaptosomal GLT-1 and GLAST during Epileptogenesis.
Peterson AR; Binder DK
Neuroscience; 2019 Jul; 411():185-201. PubMed ID: 31158434
[TBL] [Abstract][Full Text] [Related]
7. Histamine up-regulates astrocytic glutamate transporter 1 and protects neurons against ischemic injury.
Fang Q; Hu WW; Wang XF; Yang Y; Lou GD; Jin MM; Yan HJ; Zeng WZ; Shen Y; Zhang SH; Xu TL; Chen Z
Neuropharmacology; 2014 Feb; 77():156-66. PubMed ID: 23791559
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP-induced animal model of Parkinson's disease dementia.
Hsu CY; Hung CS; Chang HM; Liao WC; Ho SC; Ho YJ
Neuropharmacology; 2015 Apr; 91():43-56. PubMed ID: 25499022
[TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease.
Zumkehr J; Rodriguez-Ortiz CJ; Cheng D; Kieu Z; Wai T; Hawkins C; Kilian J; Lim SL; Medeiros R; Kitazawa M
Neurobiol Aging; 2015 Jul; 36(7):2260-2271. PubMed ID: 25964214
[TBL] [Abstract][Full Text] [Related]
10. Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders.
Ramos KM; Lewis MT; Morgan KN; Crysdale NY; Kroll JL; Taylor FR; Harrison JA; Sloane EM; Maier SF; Watkins LR
Neuroscience; 2010 Sep; 169(4):1888-900. PubMed ID: 20547213
[TBL] [Abstract][Full Text] [Related]
11. Ceftriaxone regulates glutamate production and vesicular assembly in presynaptic terminals through GLT-1 in APP/PS1 mice.
Fan S; Li L; Xian X; Liu L; Gao J; Li W
Neurobiol Learn Mem; 2021 Sep; 183():107480. PubMed ID: 34153453
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective potential of ceftriaxone in in vitro models of stroke.
Lipski J; Wan CK; Bai JZ; Pi R; Li D; Donnelly D
Neuroscience; 2007 May; 146(2):617-29. PubMed ID: 17363173
[TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats.
Das SC; Yamamoto BK; Hristov AM; Sari Y
Neuropharmacology; 2015 Oct; 97():67-74. PubMed ID: 26002627
[TBL] [Abstract][Full Text] [Related]
14. Subchronic cerebrolysin treatment alleviates cognitive impairments and dendritic arborization alterations of granular neurons in the hippocampal dentate gyrus of rats with temporal lobe epilepsy.
Zamudio SR; Pichardo-Macías LA; Díaz-Villegas V; Flores-Navarrete IL; Guzmán-Velázquez S
Epilepsy Behav; 2019 Aug; 97():96-104. PubMed ID: 31207446
[TBL] [Abstract][Full Text] [Related]
15. Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression.
LaCrosse AL; O'Donovan SM; Sepulveda-Orengo MT; McCullumsmith RE; Reissner KJ; Schwendt M; Knackstedt LA
J Neurosci; 2017 Jun; 37(24):5809-5821. PubMed ID: 28495973
[TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone rescues hippocampal neurons from excitotoxicity and enhances memory retrieval in chronic hypobaric hypoxia.
Hota SK; Barhwal K; Ray K; Singh SB; Ilavazhagan G
Neurobiol Learn Mem; 2008 May; 89(4):522-32. PubMed ID: 18304843
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation.
Chu K; Lee ST; Sinn DI; Ko SY; Kim EH; Kim JM; Kim SJ; Park DK; Jung KH; Song EC; Lee SK; Kim M; Roh JK
Stroke; 2007 Jan; 38(1):177-82. PubMed ID: 17122424
[TBL] [Abstract][Full Text] [Related]
18. Ceftriaxone-mediated upregulation of the glutamate transporter GLT-1 contrasts neurotoxicity evoked by kainate in rat organotypic spinal cord cultures.
Bajrektarevic D; Nistri A
Neurotoxicology; 2017 May; 60():34-41. PubMed ID: 28257918
[TBL] [Abstract][Full Text] [Related]
19. N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression.
Krzyzanowska W; Pomierny B; Budziszewska B; Filip M; Pera J
Neurotox Res; 2016 May; 29(4):539-50. PubMed ID: 26861954
[TBL] [Abstract][Full Text] [Related]
20. Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats.
Alhaddad H; Das SC; Sari Y
Psychopharmacology (Berl); 2014 Oct; 231(20):4049-57. PubMed ID: 24687412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
